Training future scientists to develop medications for substance use disorder
Training Program on Development of Medications for Substance Use Disorder
['FUNDING_TRAINING'] · NORTHEASTERN UNIVERSITY · NIH-10836502
This program is designed to help PhD students and postdoctoral scientists learn how to create new medications for people struggling with substance use disorders, giving them the skills and experience they need to make a real difference in treatment.
Quick facts
| Phase | ['FUNDING_TRAINING'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NORTHEASTERN UNIVERSITY (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-10836502 on ClinicalTrials.gov |
What this research studies
This program trains PhD students and postdoctoral scientists in the development of medications specifically for substance use disorder (SUD). Participants will engage in a combination of mentorship, coursework, and hands-on research activities using advanced technologies at the Center for Drug Discovery. The program aims to address the critical need for effective treatments for SUD by equipping trainees with the necessary skills and knowledge to innovate in this field. Collaborations with renowned institutions and industry experts enhance the training experience.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are individuals with a background in biomedical sciences who are pursuing advanced degrees or postdoctoral training.
Not a fit: Patients who are not pursuing a career in biomedical research or do not have an interest in drug development may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective medications for individuals suffering from substance use disorders.
How similar studies have performed: Other training programs focused on drug development have shown success in producing skilled researchers, but this specific approach to SUD medication development is relatively novel.
Where this research is happening
BOSTON, UNITED STATES
- NORTHEASTERN UNIVERSITY — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MAKRIYANNIS, ALEXANDROS — NORTHEASTERN UNIVERSITY
- Study coordinator: MAKRIYANNIS, ALEXANDROS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Substance Use Disorder, substance use and disorder